Biomarkers and Immunotherapy of Hepatic-Biliary-Pancreatic Cancers
- Yunfei Xu
- Hongda Liu
- Xuexong Gu
- Zheng Gong
Paperback & Hardcover deals ―
Amazon IndiaGOFlipkart GOSnapdealGOSapnaOnlineGOJain Book AgencyGOBooks Wagon₹4,353Book ChorGOCrosswordGODC BooksGOe-book & Audiobook deals ―
Amazon India GOGoogle Play Books GOAudible GO* Price may vary from time to time.
* GO = We're not able to fetch the price (please check manually visiting the website).
Know about the book -
Biomarkers and Immunotherapy of Hepatic-Biliary-Pancreatic Cancers is written by Yunfei Xu and published by Frontiers Media SA. It's available with International Standard Book Number or ISBN identification 2832540376 (ISBN 10) and 9782832540374 (ISBN 13).
Hepatic-biliary-pancreatic cancers, mainly including hepatocellular carcinoma, cholangiocarcinoma, gallbladder cancer, are highly aggressive malignancies with few treatment options and poor prognoses. Effects of the traditional systemic treatments such as chemotherapy and radiotherapy, are quite limited to hepatic-biliary-pancreatic cancers. For the patients who suffer from hepatic-biliary-pancreatic cancer and lose the opportunity of radical surgery, few targeted drugs are available. Even for the drugs in clinical trial, potential drug targets and prognostic biomarkers for hepatic-biliary-pancreatic cancer are less studied compared to other common cancers such as lung cancer. Prognostic biomarker study is the initiation to explore new drug targets and revelation of the underlying mechanisms of tumor progression.
